News Archives - Page 2 of 4 - NFCR

News

Medical Coalition Led Largely by NFCR Unites to Battle Glioblastoma

Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is the first platform trial for…...

Read more

Bringing International Partners Together

(clockwise) NFCR President Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin In recent months, the National Foundation for Cancer Research (NFCR) has signed memorandums of understanding with two major foreign institutions, the China Pharmaceutical Innovation and Research Development Association (PhIRDA) and the Australia-based…...

Read more

NFCR at the 2018 American Association for Cancer Research Annual Meeting

The National Foundation for Cancer Research’s (NFCR) presence is considerable at the 109th annual meeting of the American Association for Cancer Research (AACR), which kicks off tomorrow in Chicago and runs through the following four days. One of the most widely anticipated regular gatherings of cancer scientists in the United…...

Read more

Two National Foundation for Cancer Research Scientists Among the National Academy of Inventors’ Latest Class

FOR IMMEDIATE RELEASE: April 5, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Honor Recognizes Top Academic Inventors BETHESDA, MD – In an event this afternoon at the historic Mayflower Hotel in Washington, DC, two funded scientists of the National Foundation…...

Read more

Global Collaborative Network Expands to Include Australia’s Eliminate Cancer Initiative

The National Foundation for Cancer Research (NFCR) today inked its second memorandum of understanding (MOU) within the past half year among major transnational cancer-fighting institutions. This pledge of cooperation follows on the heels of the formal commitment between the chairmen of itself and the China Pharmaceutical Innovation and Research Development…...

Read more

Safeway Foundation Grant Designated

The Safeway Foundation provided the National Foundation for Cancer Research (NFCR) a $50,000 grant to support innovative oncology research. The donation has been designated to NFCR Fellow Paul B. Fisher, M.Ph., Ph.D., at the Virginia Commonwealth University School of Medicine. The funds from The Safeway Foundation are being used to…...

Read more

NFCR Leads Delegation to Chinese BioMed Conference, Signs MOU with Host

The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...

Read more

NFCR President and COO to co-organize and speak at SNOChina 2018

The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the president and chief operating officer of the National Foundation for Cancer Research (NFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha, Hunan on March 16-17, 2018.  The Society will present the…...

Read more

On the Move with Dr. Ba

This year, cancer research is moving at an exciting pace towards a real transformation. Just last month, the U.S. Food and Drug Administration approved a cancer treatment based on a biomarker rather than the body location where the cancer originates....

Read more

Welcome to Our NEW Website

After six months of hard work and dedication, we are delighted to officially announce the launch of the new and improved www.nfcr.org....

Read more